Corporate News     22-Feb-21
Vivimed Labs receives Uzbekistan Government approval for Febril Syrup
Vivimed Labs has received approval for 1 product from Uzbekistan Government for its PICS & Health Canada approved site, both facilities are situated at Hyderabad.

PRODUCT: Paracetamol 125mg/5ml + Chlorpheniramine Maleate 2.5mg/5ml syrup under brand name FEBRIL Syrup 100ml

USES: Paracetamol is also known as acetaminophen, is a medication used to treat pain and fever. Chlorpheniramine is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold.

Previous News
  Vivimed Labs to discuss results
 ( Corporate News - 23-Aug-24   19:39 )
  Vivimed Labs to convene EGM
 ( Corporate News - 08-Jul-24   10:49 )
  Vivimed Labs to hold board meeting
 ( Corporate News - 29-Jun-24   17:38 )
  Vivimed Labs postpones board meeting
 ( Corporate News - 18-May-24   11:32 )
  Vivimed Labs to table results
 ( Corporate News - 08-May-24   15:36 )
  Vivimed Labs reports consolidated net loss of Rs 16.05 crore in the December 2023 quarter
 ( Results - Announcements 15-Feb-24   07:41 )
  Vivimed Labs to discuss results
 ( Corporate News - 01-Feb-24   10:55 )
  Vivimed Labs reports consolidated net loss of Rs 20.30 crore in the September 2023 quarter
 ( Results - Announcements 16-Nov-23   12:49 )
  Vivimed Labs schedules board meeting
 ( Corporate News - 30-Oct-23   18:24 )
  Vivimed Labs AGM scheduled
 ( Corporate News - 19-Oct-23   15:55 )
  Vivimed Labs reports consolidated net loss of Rs 15.58 crore in the June 2023 quarter
 ( Results - Announcements 15-Aug-23   09:27 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top